Enzo Biochem, Inc. (ENZ)

Market Cap	55.84M
Revenue (ttm)	12.81M
Net Income (ttm)	32.57M
Shares Out	51.23M
EPS (ttm)	0.67
PE Ratio	1.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,123
Open	1.080
Previous Close	1.090
Day's Range	1.080 - 1.110
52-Week Range	1.070 - 2.740
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 12, 2024

About ENZ

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1976
• Employees: 179
• Stock Exchange: NYSE
• Ticker Symbol: ENZ